If you think that, you clearly don't understand the rest of the market. But that's ok. You're entitled to your view.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025